🇺🇸 FDA
Patent

US 7098364

Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof

granted A61PA61P11/00A61P11/04

Quick answer

US patent 7098364 (Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof) held by Jinzhou Jiutai Pharmaceutical Co., Ltd., China expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jinzhou Jiutai Pharmaceutical Co., Ltd., China
Grant date
Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P11/00, A61P11/04, A61P11/06, A61P29/00